Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;182(11):2508-2520.
doi: 10.1002/ajmg.a.61813. Epub 2020 Aug 21.

Screening of a large Rubinstein-Taybi cohort identified many novel variants and emphasizes the importance of the CREBBP histone acetyltransferase domain

Esther Cross  1 , Philippa J Duncan-Flavell  1 , Rachel J Howarth  1 , James I Hobbs  1 , Nicholas Simon Thomas  1   2 , David J Bunyan  1   2
Affiliations

Screening of a large Rubinstein-Taybi cohort identified many novel variants and emphasizes the importance of the CREBBP histone acetyltransferase domain

Esther Cross et al. Am J Med Genet A. 2020 Nov.

Abstract

Pathogenic variants within the CREBBP and EP300 genes account for the majority of individuals with Rubinstein-Taybi syndrome (RSTS). Data are presented from a large cohort of 395 individuals referred for diagnostic testing of CREBBP, and of the 19 CREBBP missense variants classified as likely pathogenic in this study, 17 were within the histone acetyltransferase (HAT) domain, providing evidence that this domain is critical to the normal function of the CREBBP protein (CBP). The data presented here, combined with other published results, suggest that the presence of a missense variant within the CBP HAT domain can be considered as moderate evidence of pathogenicity in the context of official variant interpretation guidelines. Within our study cohort, 129 had a pathogenic or likely pathogenic CREBBP variant and 5 had a variant of uncertain significance (VUS) which warranted familial studies. 147 of the remaining probands were also screened for EP300 and a further 16 pathogenic or likely pathogenic variants were identified, plus one VUS. Therefore, this analysis has provided a molecular diagnosis in at least 145 individuals with RSTS (37%) and identified a wide range of variants (n = 133) of which 103 were novel.

Keywords: CREBBP; DNA mutational analysis; EP300; Rubinstein-Taybi syndrome.

PubMed Disclaimer

References

REFERENCES

    1. Arany, Z., Sellers, W. R., Livingston, D. M., & Eckner, R. (1994). E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell, 77(6), 799-800.
    1. Banka, S., Sayer, R., Breen, C., Barton, S., Pavaine, J., Sheppard, S. E., … Clayton-Smith, J. (2019). Genotype-phenotype specificity in Menke-Hennekam syndrome caused by missense variants in exon 30 or 31 of CREBBP. American Journal of Medical Genetics. Part A, 179(6), 1058-1062.
    1. Bartsch, O., Schmidt, S., Richter, M., Morlot, S., Seemanová, E., Wiebe, G., & Rasi, S. (2005). DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Human Genetics, 117, 485-493.
    1. Bartsch, O., Labonté, J., Albrecht, B., Wieczorek, D., Lechno, S., Zechner, U., & Haaf, T. (2010a). Two patients with EP300 mutations and facial dysmorphism different from the classic Rubinstein-Taybi syndrome. American Journal of Medical Genetics. Part A, 152A(1), 181-184.
    1. Bartsch, O., Kress, W., Kempf, O., Lechno, S., Haaf, T., & Zechner, U. (2010b). Inheritance and variable expression in Rubinstein-Taybi syndrome. American Journal of Medical Genetics. Part A, 152A(9), 2254-2261.

LinkOut - more resources